• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液透析患者内脏脂肪蓄积指标与心血管风险。

Visceral adiposity indicators and cardiovascular risk in hemodialytic patients.

机构信息

Programa de Pós-graduação em Nutrição, Universidade Federal de Pernambuco, Recife, PE, Brasil,

Departamento de Saúde Pública, Universidade Federal do Maranhão, São Luís, MA, Brasil.

出版信息

Arch Endocrinol Metab. 2021 Nov 24;65(6):811-820. doi: 10.20945/2359-3997000000421. Epub 2021 Nov 11.

DOI:10.20945/2359-3997000000421
PMID:34762791
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10065383/
Abstract

OBJECTIVE

Cardiovascular diseases represent the main cause of death in chronic kidney disease (CKD). We aimed to evaluate the prevalence and association of the hypertriglyceridemia-waist phenotype (HWP) and visceral adiposity index (VAI) with cardiometabolic risk factors (CR) in patients with CKD on hemodialysis (HD).

METHODS

The study is based on a cross-sectional design with 265 HD patients in two cities in northeastern Brazil. The VAI was calculated considering the variables body mass index (BMI), waist circumference (WC), triglycerides (TG) and high density lipoprotein cholesterol (HDL-c). HWP was defined as the concomitant elevation of WC and TG. The Poisson Regression Model with robust variance estimation was adjusted considering a hierarchical approach for explanatory variables. Prevalence ratios (PR) were also estimated. The level of significance adopted was 5%.

RESULTS

In our study HWP and VAI prevalence's were 29.82% and 58.49%, respectively. In the final model, there was an association between VAI and female gender (PR = 1.46; p < 0.0001) and high body fat (% BF) (PR = 1.33; p < 0.0019). HWP was associated with females (PR = 1.80; p = 0.002), alcohol consumption (PR = 1.58; p = 0.033), obesity (PR = 1.89; p = 0.0001), high %BF (PR = 1.76; p = 0.012) and reduced HDL-c (PR = 1.48; p = 0.035).

CONCLUSION

The HWP stood out as the association with more CR factors, representing a promising method for tracking cardiometabolic risk in HD patients, mainly female.

摘要

目的

心血管疾病是慢性肾脏病(CKD)患者死亡的主要原因。本研究旨在评估血脂异常-腰围表型(HWP)和内脏脂肪指数(VAI)与接受血液透析(HD)治疗的 CKD 患者心血管代谢风险因素(CR)的相关性。

方法

本研究基于巴西东北部两个城市的 265 名 HD 患者的横断面设计。VAI 是通过考虑体重指数(BMI)、腰围(WC)、甘油三酯(TG)和高密度脂蛋白胆固醇(HDL-c)等变量计算得出的。HWP 定义为 WC 和 TG 同时升高。采用具有稳健方差估计的 Poisson 回归模型进行调整,并考虑了分层解释变量的方法。还估计了患病率比(PR)。采用 5%的显著性水平。

结果

在我们的研究中,HWP 和 VAI 的患病率分别为 29.82%和 58.49%。在最终模型中,VAI 与女性(PR=1.46;p<0.0001)和高体脂肪(%BF)(PR=1.33;p<0.0019)呈正相关。HWP 与女性(PR=1.80;p=0.002)、饮酒(PR=1.58;p=0.033)、肥胖(PR=1.89;p=0.0001)、高 %BF(PR=1.76;p=0.012)和低 HDL-c(PR=1.48;p=0.035)相关。

结论

HWP 与更多的 CR 因素相关,是一种有前途的方法,可以跟踪 HD 患者的心血管代谢风险,特别是女性。

相似文献

1
Visceral adiposity indicators and cardiovascular risk in hemodialytic patients.血液透析患者内脏脂肪蓄积指标与心血管风险。
Arch Endocrinol Metab. 2021 Nov 24;65(6):811-820. doi: 10.20945/2359-3997000000421. Epub 2021 Nov 11.
2
LIPID ACCUMULATION PRODUCT, VISCERAL ADIPOSITY INDEX, AND CHINESE VISCERAL ADIPOSITY INDEX AS MARKERS OF CARDIOMETABOLIC RISK IN ADULT GROWTH HORMONE DEFICIENCY PATIENTS: A CROSS-SECTIONAL STUDY.脂积累产物、内脏脂肪指数和中国内脏脂肪指数作为成年生长激素缺乏症患者心血管代谢风险的标志物:一项横断面研究。
Endocr Pract. 2018 Jan;24(1):33-39. doi: 10.4158/EP-2017-0007. Epub 2017 Nov 16.
3
Visceral Adiposity Index and Lipid Accumulation Product Index: Two Alternate Body Indices to Identify Chronic Kidney Disease among the Rural Population in Northeast China.内脏脂肪指数和脂质蓄积产物指数:中国东北农村人群中用于识别慢性肾脏病的两种替代身体指标
Int J Environ Res Public Health. 2016 Dec 13;13(12):1231. doi: 10.3390/ijerph13121231.
4
Identification of cardiometabolic risk: visceral adiposity index versus triglyceride/HDL cholesterol ratio.识别心血管代谢风险:内脏脂肪指数与甘油三酯/高密度脂蛋白胆固醇比值。
Am J Med. 2014 Feb;127(2):152-7. doi: 10.1016/j.amjmed.2013.10.012. Epub 2013 Nov 1.
5
SUITABILITY OF VISCERAL ADIPOSITY INDEX AS A MARKER FOR CARDIOMETABOLIC RISKS IN JORDANIAN ADULTS.内脏脂肪指数作为约旦成年人心脏代谢风险标志物的适用性
Nutr Hosp. 2015 Dec 1;32(6):2701-9. doi: 10.3305/nh.2015.32.6.9543.
6
The visceral adiposity index is a predictor of incident nonalcoholic fatty liver disease: A population-based longitudinal study.内脏脂肪指数是预测非酒精性脂肪肝发病的指标:一项基于人群的纵向研究。
Clin Res Hepatol Gastroenterol. 2020 Jun;44(3):375-383. doi: 10.1016/j.clinre.2019.04.002. Epub 2020 May 17.
7
Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk.内脏脂肪指数:与心血管代谢风险相关的内脏脂肪功能的可靠指标。
Diabetes Care. 2010 Apr;33(4):920-2. doi: 10.2337/dc09-1825. Epub 2010 Jan 12.
8
Visceral Adiposity Index as an Indicator of Cardiometabolic Risk in Patients with Congenital Adrenal Hyperplasia.内脏脂肪指数作为先天性肾上腺皮质增生症患者心脏代谢风险的指标
Metab Syndr Relat Disord. 2023 Feb;21(1):35-40. doi: 10.1089/met.2022.0060. Epub 2022 Dec 20.
9
Central obesity and risks of cardiovascular events and mortality in prevalent hemodialysis patients.维持性血液透析患者的中心性肥胖与心血管事件及死亡风险
Int Urol Nephrol. 2017 Jul;49(7):1251-1260. doi: 10.1007/s11255-017-1568-0. Epub 2017 Mar 17.
10
Visceral adiposity index and atherogenic index of plasma as useful predictors of risk of cardiovascular diseases: evidence from a cohort study in Iran.内脏脂肪指数和血浆致动脉粥样硬化指数是心血管疾病风险的有用预测指标:来自伊朗队列研究的证据。
Lipids Health Dis. 2021 Aug 1;20(1):82. doi: 10.1186/s12944-021-01505-w.

引用本文的文献

1
Perspective from NHANES data: synergistic effects of visceral adiposity index and lipid accumulation products on diabetes risk.基于美国国家健康与营养检查调查(NHANES)数据的视角:内脏脂肪指数与脂质蓄积产物对糖尿病风险的协同作用
Sci Rep. 2025 Jan 2;15(1):258. doi: 10.1038/s41598-024-84034-7.
2
Importance of cardiac imaging assessment of epicardial adipose tissue after a first episode of myocardial infarction.首次心肌梗死后心外膜脂肪组织心脏成像评估的重要性。
Front Cardiovasc Med. 2022 Nov 14;9:995367. doi: 10.3389/fcvm.2022.995367. eCollection 2022.

本文引用的文献

1
Total oxidant status and oxidative stress index as indicators of increased Reynolds risk score in postmenopausal women.总氧化剂状态和氧化应激指数作为绝经后妇女雷诺氏风险评分升高的指标。
Eur Rev Med Pharmacol Sci. 2020 Oct;24(19):10126-10133. doi: 10.26355/eurrev_202010_23232.
2
Sarcopenia and inflammation in patients undergoing hemodialysis.接受血液透析患者的肌肉减少症与炎症
Nutr Hosp. 2020 Aug 27;37(4):855-862. doi: 10.20960/nh.03068.
3
Comparison of visceral, general and central obesity indices in the prediction of metabolic syndrome in maintenance hemodialysis patients.比较维持性血液透析患者内脏型肥胖、全身型肥胖和中心型肥胖指数对代谢综合征的预测价值。
Eat Weight Disord. 2020 Jun;25(3):727-734. doi: 10.1007/s40519-019-00678-9. Epub 2019 Apr 9.
4
The associations of fat tissue and muscle mass indices with all-cause mortality in patients undergoing hemodialysis.接受血液透析患者的脂肪组织和肌肉质量指数与全因死亡率的相关性。
PLoS One. 2019 Feb 13;14(2):e0211988. doi: 10.1371/journal.pone.0211988. eCollection 2019.
5
Visceral, general, abdominal adiposity and atherogenic index of plasma in relatively lean hemodialysis patients.相对瘦的血液透析患者的内脏脂肪、总体脂肪、腹部肥胖及血浆致动脉粥样硬化指数
BMC Nephrol. 2018 Aug 16;19(1):206. doi: 10.1186/s12882-018-0996-0.
6
Expenses of the Brazilian Public Healthcare System with chronic kidney disease.巴西公共医疗系统在慢性肾病方面的支出。
J Bras Nefrol. 2018 Apr-Jun;40(2):122-129. doi: 10.1590/2175-8239-JBN-3918. Epub 2018 Jun 4.
7
[Hypertriglyceridemic waist phenotype: associated factors and comparison with other cardiovascular and metabolic risk indicators in the ELSA-Brasil study].[高甘油三酯血症腰围表型:ELSA-Brasil研究中的相关因素及与其他心血管和代谢风险指标的比较]
Cad Saude Publica. 2018 Mar 29;34(4):e00067617. doi: 10.1590/0102-311X00067617.
8
Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update.慢性肾脏病-矿物质和骨异常的诊断、评估、预防和治疗:肾脏病改善全球结局组织 2017 年临床实践指南更新概要。
Ann Intern Med. 2018 Mar 20;168(6):422-430. doi: 10.7326/M17-2640. Epub 2018 Feb 20.
9
Central obesity and risks of cardiovascular events and mortality in prevalent hemodialysis patients.维持性血液透析患者的中心性肥胖与心血管事件及死亡风险
Int Urol Nephrol. 2017 Jul;49(7):1251-1260. doi: 10.1007/s11255-017-1568-0. Epub 2017 Mar 17.
10
Association of body weight changes with mortality in incident hemodialysis patients.体重变化与新进入血液透析患者死亡率的相关性。
Nephrol Dial Transplant. 2017 Sep 1;32(9):1549-1558. doi: 10.1093/ndt/gfw373.